Design and synthesis of the cartilage protective agent (CPA, Ro32-3555)
- 9 September 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (17), 2299-2302
- https://doi.org/10.1016/s0960-894x(97)00416-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitorsBiochemical Journal, 1997
- Recent advances in matrix metalloproteinase inhibitor researchDrug Discovery Today, 1996
- Relationship between structure and bioavailability in a series of hydroxamate based metalloprotease inhibitorsBioorganic & Medicinal Chemistry Letters, 1995
- Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitorNature Structural & Molecular Biology, 1994
- A novel in vivo model for the study of cartilage degradationJournal of Pharmacological and Toxicological Methods, 1993
- 8 Synthetic Inhibitors of Bacterial and Mammalian Interstitial CollagenasesProgress in Medicinal Chemistry, 1992
- Intraarticular injection ofPropionibacterium acnes causes an erosive arthritis in ratsInflammation Research, 1987
- Collagenase Inhibitors: Their Design and Potential Therapeutic UseJournal of Enzyme Inhibition, 1987
- Transformation of Carboxylic Acidt-Butyl Esters into the Corresponding Trimethylsilyl Esters or Free Acids under Non-Acidic ConditionsSynthesis, 1980
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967